Conventional injection molding involves injecting molten plastic into a mold under high pressure to fill the cavity. iMFLUX, a wholly owned subsidiary of Procter and Gamble, started as a platform technology based on an innovation around the process of injecting the molten plastic into the mold at a constant low pressure. This disruptive process provided many benefits such as higher part quality, lower molded-in stresses and faster cycles with additional savings from lower injection and clamping pressure.
This innovative technology allowed iMFLUX to think differently about how molds are designed and how they’re constructed and ultimately challenging some of the design standards that exist in mold building today. Some of the extraordinary results iMFLUX achieved from this technology are:
- Part cost reduction due to 20—30% throughput increase, lower part weight and reduced scrap
- Improved cash efficiency due to lower press investment and instant capacity
- Enabling a more sustainable process due to lower energy costs and use of post-consumer recyclable and renewable material
